Chronic diseases 3 - Chronic disease prevention: health effects and financial costs of strategies to reduce salt intake and control tobacco use

被引:415
作者
Asaria, Perviz
Chisholm, Dan [1 ]
Mathers, Colin
Ezzati, Majid
Beaglehole, Robert
机构
[1] WHO, Dept Hlth Syst Financing, CH-1211 Geneva 27, Switzerland
[2] Kings Fund, London, England
[3] Univ Auckland, Auckland 1, New Zealand
[4] WHO, Dept Measurement & Hlth Informat Syst, CH-1211 Geneva, Switzerland
[5] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA
关键词
D O I
10.1016/S0140-6736(07)61698-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In 2005, WHO set a global goal to reduce rates of death from chronic (non-communicable) disease by an additional 2% every year. To this end, we investigated how many deaths could potentially be averted over 10 years by implementation of selected population-based interventions, and calculated the financial costs of their implementation. We selected two interventions: to reduce salt intake in the population by 15% and to implement four key elements of the WHO Framework Convention on Tobacco Control (FCTC). We used methods from the WHO Comparative Risk Assessment project to estimate shifts in the distribution of risk factors associated with salt intake and tobacco use, and to model the effects on chronic disease mortality for 23 countries that account for 80% of chronic disease burden in the developing world. We showed that, over 10 years (2006-2015), 13.8 million deaths could be averted by implementation of these interventions, at a cost of less than US$0.40 per person per year in low-income and lower middle-income countries, and US$0.50-1.00 per person per year in upper middle-income countries (as of 2005). These two population-based intervention strategies could therefore substantially reduce mortality from chronic diseases, and make a major (and affordable) contribution towards achievement of the global goal to prevent and control chronic diseases.
引用
收藏
页码:2044 / 2053
页数:10
相关论文
共 65 条
[1]   Chronic diseases 1 - The burden and costs of chronic diseases in low-income and middle-income countries [J].
Abegunde, Dele O. ;
Mathers, Colin D. ;
Adam, Taghreed ;
Ortegon, Monica ;
Strong, Kathleen .
LANCET, 2007, 370 (9603) :1929-1938
[2]  
[Anonymous], 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD004937
[3]  
[Anonymous], 2007, WORLD DEV IND
[4]  
[Anonymous], 2001, MACROECONOMICS HLTH
[5]   A community programme to reduce salt intake and blood pressure in Ghana [ISRCTN88789643] [J].
Cappuccio, FP ;
Kerry, SM ;
Micah, FB ;
Plange-Rhule, J ;
Eastwood, JB .
BMC PUBLIC HEALTH, 2006, 6 (1) :11P
[6]   BLOOD-PRESSURE IN 4 REMOTE POPULATIONS IN THE INTERSALT STUDY [J].
CARVALHO, JJM ;
BARUZZI, RG ;
HOWARD, PF ;
POULTER, N ;
ALPERS, MP ;
FRANCO, LJ ;
MARCOPITO, LF ;
SPOONER, VJ ;
DYER, AR ;
ELLIOTT, P ;
STAMLER, J ;
STAMLER, R .
HYPERTENSION, 1989, 14 (03) :238-246
[7]   Long term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow-up of the trials of hypertension prevention (TOHP) [J].
Cook, Nancy R. ;
Cutler, Jeffrey A. ;
Obarzanek, Eva ;
Buring, Julie E. ;
Rexrode, Kathryn M. ;
Kumanyika, Shiriki K. ;
Appel, Lawrence J. ;
Whelton, Paul K. .
BMJ-BRITISH MEDICAL JOURNAL, 2007, 334 (7599) :885-888B
[8]  
DAY NE, 1997, BMJ-BRIT MED J, V315, P484
[9]  
ELLIOTT P, 1988, BRIT MED J, V297, P319
[10]   Intersalt revisited: Further analyses of 24 hour sodium excretion and blood pressure within and across populations [J].
Elliott, P ;
Stamler, J ;
Nichols, R ;
Dyer, AR ;
Stamler, R ;
Kesteloot, H ;
Marmot, M .
BMJ-BRITISH MEDICAL JOURNAL, 1996, 312 (7041) :1249-1253